Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Payne

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|March 8, 1975
Letter: Whooping-cough vaccinationJ V Gostling, D J Payne
Journal of Medical Microbiology|February 1, 1993
Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamasesD J Payne, S G Amyes
The Journal of Antimicrobial Chemotherapy|November 1, 1991
The automated in-vitro assessment of beta-lactamase inhibitorsD J Payne, K Coleman, R Cramp
Current Opinion in Pharmacology|January 5, 2002
Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developmentsL A Miller, K Ratnam, D J Payne
Expert Opinion on Investigational Drugs|November 4, 2000
beta-Lactamase epidemiology and the utility of established and novel beta-lactamase inhibitorsD J Payne, W Du, J H Bateson
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Delivering novel targets and antibiotics from genomicsD J Payne, D J Holmes, M Rosenberg
Journal of Enzyme Inhibition|January 5, 2001
The kinetic mechanism of 5-enolpyruvylshikimate-3-phosphate synthase from a gram-positive pathogen Streptococcus pneumoniaeW Du, N G Wallis, D J Payne
Biochemical and Biophysical Research Communications|February 7, 2001
A conserved residue at the extreme C-terminus of FtsZ is critical for the FtsA-FtsZ interaction in Staphylococcus aureusK Yan, K H Pearce, D J Payne
Lancet (London, England)|April 3, 1982
Necrotising otitis externa and diabetic controlA Resouly, D J Payne, K M Shaw
The Journal of Antimicrobial Chemotherapy|August 1, 1992
Characterization of the plasmid mediated beta-lactamase BIL-1D J Payne, N Woodford, S G Amyes
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|March 8, 1975
Letter: Whooping-cough vaccinationJ V Gostling, D J Payne
Journal of Medical Microbiology|February 1, 1993
Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamasesD J Payne, S G Amyes
The Journal of Antimicrobial Chemotherapy|November 1, 1991
The automated in-vitro assessment of beta-lactamase inhibitorsD J Payne, K Coleman, R Cramp
Current Opinion in Pharmacology|January 5, 2002
Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developmentsL A Miller, K Ratnam, D J Payne
Expert Opinion on Investigational Drugs|November 4, 2000
beta-Lactamase epidemiology and the utility of established and novel beta-lactamase inhibitorsD J Payne, W Du, J H Bateson
Current Opinion in Investigational Drugs (London, England : 2000)|March 15, 2002
Delivering novel targets and antibiotics from genomicsD J Payne, D J Holmes, M Rosenberg
Journal of Enzyme Inhibition|January 5, 2001
The kinetic mechanism of 5-enolpyruvylshikimate-3-phosphate synthase from a gram-positive pathogen Streptococcus pneumoniaeW Du, N G Wallis, D J Payne
Biochemical and Biophysical Research Communications|February 7, 2001
A conserved residue at the extreme C-terminus of FtsZ is critical for the FtsA-FtsZ interaction in Staphylococcus aureusK Yan, K H Pearce, D J Payne
Lancet (London, England)|April 3, 1982
Necrotising otitis externa and diabetic controlA Resouly, D J Payne, K M Shaw
The Journal of Antimicrobial Chemotherapy|August 1, 1992
Characterization of the plasmid mediated beta-lactamase BIL-1D J Payne, N Woodford, S G Amyes
Pageof 30